Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Show full CV Hide full CV

Latest news & insights

Pills
Life sciences & healthcare

OLG Frankfurt am Main: Distribution of free drug samples to pharmacists

13 December 2022
Quick read

by Dr. Daniel Tietjen

Click here to find out more
Pills
Life sciences & healthcare

ECJ: Requirements for the repackaging of medicinal products in view of the new anti-counterfeiting regulations

13 December 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Life sciences & healthcare

BGH: Berlin convictions for trafficking in CBD flowers legally binding

13 December 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Laboratory pipettes
Life sciences & healthcare

Federal Social Court: High barriers for cannabis on health insurance prescription

13 December 2022
Quick read

by Dr. Daniel Tietjen

Click here to find out more

Related people

Meet me at

There are no upcoming events